# Wilmington Investor Network

> Wilmington Investor Network is a VC fund backing Health Care. See 19 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Wilmington, United States
- Total investments: 19
- Last investment: Dec 2018
- Lead investor: 11%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/w.i.n.-wilmington-investor-network
- Website: http://www.wilmingtoninvestor.com

Wilmington Investor Network is a private equity fund of angel investors.

## Contacts

5 contacts available for Wilmington Investor Network. Shizune tracks 4 team members at Wilmington Investor Network. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/wilmington-investor-network?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 9 | 47% |
| Biotechnology | 7 | 37% |
| Software | 3 | 16% |
| Medical Device | 3 | 16% |
| Biopharma | 2 | 11% |

42 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 6 | 32% |
| Seed | 5 | 26% |
| Series B | 4 | 21% |
| Angel | 1 | 5% |
| Series C | 1 | 5% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 15 | 79% |
| Canada | 2 | 11% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Michael G. Cain | Managing Member & Founder | 0 | — |
| Scott Sullivan | Member | 0 | — |
| Carlos Parajon | Angel Investor | 3 | — |
| Jen Wege | Investor & Member | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Tunnel | Tunnel is a fintech company that provides offers real-time cross-currency payments services.The company utilizes a Distributed Ledger Technology (DLT) to offer no transaction fee processing. It also provides payment rails, APIs, and mobile apps.Frank Makrides, Mariana Jbantova Svirchuk, and Neil Ratna established Tunnel in Boston, Massachusettsin 2018. |  | Seed | Dec 15, 2018 |  |
| Roobrik | Roobrik is an online platform that helps older adults and families make informed health and care decisions and connect to the products, services, and programs that can help. | $1.4M | Seed | Sep 11, 2018 |  |
| Meta Materials | META® delivers previously unachievable performance, across a range of applications, by inventing, designing, developing, and manufacturing sustainable, highly functional materials. Our extensive technology platform enables leading global brands to deliver breakthrough products to their customers in consumer electronics, 5G communications, healthand wellness, aerospace, automotive, and clean energy. Our nano-optic technology provides anti-counterfeiting security features for government documents and currencies and authentication for brands. Our achievements have been widely recognized, including being named a Lux Research Innovator of the Year in 2021. Learn more at www.metamaterial.com. | $3.1M | Seed | Apr 23, 2015 |  |
| Avhana Health | Avhana Health operates a value-based care enablement platform. It is driven by a mission to offer impactful, patient-specific support for healthcare teams. The company was founded in 2014 and is headquartered in Baltimore, Maryland. | $750K | Seed | Dec 22, 2014 |  |
| Validic | Validic is the healthcare industry's premier technology platform for convenient, easy data access to a world of mobile health and in-home devices, fitness equipment, clinical sensors, activity wearables, smart bands, and wellness applications. Founded in 2010, Validic is headquartered in Durham, North Carolina. | $5M | Series A | Aug 12, 2014 |  |
| Gemmus Pharma | Gemmus Pharma is a drug development company founded in 2007 to commercialize in-licensed technology from a major pharmaceutical company. Gemmus' lead candidate is a cardiovascular drug currently marketed in Asia that has been repurposed for use as a treatment for influenza. Gemmus has received support from the National Institute of Allergy andInfectious Disease (NIAID) and has completed a Series A round. Gemmus plans to file an investigational new drug (IND) application with the FDA for treatment of influenza infections in 2014. | $3.3M | Series B | May 13, 2014 |  |
| Trusted Metrics | Trusted Metrics provides Elastic SOC®, a multi-tenant, cloud-based platform which gives organizations of any size the ability to incorporate SIEM as a framework for centralized log correlation, as well as intrusion detection, asset management, vulnerability management, threat intelligence, alarm generation and network performance management into asingle console. This solution was specifically designed with managed service providers (MSPs) and managed security service providers (MSSPs) in mind, giving them the ability to deploy a white-labeled virtual Security Operations Center (SOC) for their clients, enabling around-the-clock network security monitoring, protection and response. Elastic SOC® allows any organization the ability to quickly analyze threats, provide on-demand or scheduled reporting on IT Operations, receive real-time alerts when unfavorable conditions occur, or perform long-term forensic analysis. Proud to be named a Red Herring Global 100 Finalist for 2016 and CRN's Coolest Emerging Vendors for 2015 and 2016, we are dedicated to our channel partners by providing a multi-tenant offering that allows unprecedented visibility into their clients' networks. |  | Seed | May 01, 2014 |  |
| ABK Biomedical | ABK Biomedical combines the clinical market with biomaterials. It specializes in improving treatment options for patients with hypervascular tumors. The company is dedicated to transforming an interventional radiology procedure called embolization. |  | Angel | Jan 01, 2014 |  |
| Chaologix | Chaologix is an early-stage company that develops computing architecture and chip sets. It plans to create processor and architecture, based on “chaotic circuit” elements, chaotic gate arrays, and various applications utilizing these components. | $1.5M | Series C | Oct 01, 2013 |  |
| Gemmus Pharma | Gemmus Pharma is a drug development company founded in 2007 to commercialize in-licensed technology from a major pharmaceutical company. Gemmus' lead candidate is a cardiovascular drug currently marketed in Asia that has been repurposed for use as a treatment for influenza. Gemmus has received support from the National Institute of Allergy andInfectious Disease (NIAID) and has completed a Series A round. Gemmus plans to file an investigational new drug (IND) application with the FDA for treatment of influenza infections in 2014. | $1.8M | Series A | Jun 28, 2012 |  |

10 of 19 investments shown.

## Co-investors
- Harbor Island Equity Partners — VC Fund, 3 deals together
- [Life Science Angels](https://shizune.co/investors/profile/life-science-angels) — VC Fund, 3 deals together
- [BlueTree Allied Angels](https://shizune.co/investors/profile/bluetree-allied-angels) — VC Fund, 2 deals together
- [Boston Millennia Partners](https://shizune.co/investors/profile/boston-millennia-partners) — VC Fund, 2 deals together
- [First Angel Network](https://shizune.co/investors/profile/first-angel-network) — VC Fund, 2 deals together
- Springboard Capital — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Wilmington Investor Network invest in?

Wilmington Investor Network invests primarily in Health Care, Biotechnology and Software startups, most often at Series A and Seed stage. Most of the 19 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Wilmington Investor Network?

Public channels for Wilmington Investor Network include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Wilmington Investor Network?

The team at Wilmington Investor Network includes Michael G. Cain (Managing Member & Founder), Scott Sullivan (Member) and Carlos Parajon (Angel Investor). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co